Accessibility Menu
AlphaTON Capital Stock Quote

AlphaTON Capital (NASDAQ: PRTG)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
N/A
Daily Change
N/A
Day's Range
N/A
Previous Close
N/A
Open
N/A
Beta
N/A
Volume
N/A
Average Volume
N/A
Market Cap
N/A
Market Cap / Employee
N/A
52wk Range
N/A
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
N/A
CAPs Rating
N/A
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

AlphaTON Capital Company Info

Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. Its portfolio includes subsidiary companies, whose products or technologies have established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. It provides funding, strategic business and clinical counsel, and shared services to treat different types of cancers. The company was founded by Gregory H. Bailey in 1973 and is headquartered in Road Town, British Virgin Islands.

News & Analysis

No results found

No news articles found for AlphaTON Capital.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.